Bauer Christoph Alexander, Grimme Stefan
Mulliken Center for Theoretical Chemistry, Institut für Physikalische und Theoretische Chemie, Rheinische Friedrich-Wilhelms-Universität Bonn, Beringstr. 4, D-53115 Bonn, Germany.
Org Biomol Chem. 2014 Nov 21;12(43):8737-44. doi: 10.1039/c4ob01668h.
This study presents a showcase for the novel Quantum Chemistry Electron Ionization Mass Spectrometry (QCEIMS) method on five FDA-approved drugs. The method allows a first-principles electronic structure-based prediction of EI mass spectra in principle for any molecule. The systems in this case study are organic substances of nominal masses between 404 and 853 atomic mass units and cover a wide range of functional groups and organic molecular structure motifs. The results demonstrate the widespread applicability of the QCEIMS method for the unbiased computation of EI mass spectra even for larger molecules. Its strengths compared to standard (static) or database driven approaches in such cases are highlighted. Weak points regarding the required computation times or the approximate character of the employed QC methods are also discussed. We propose QCEIMS as a viable and robust way of predicting EI mass spectra for sizeable organic molecules relevant to medicinal and pharmaceutical chemistry.
本研究展示了新型量子化学电子电离质谱法(QCEIMS)在五种美国食品药品监督管理局(FDA)批准药物上的应用。该方法原则上允许基于第一性原理电子结构对任何分子的电子电离质谱进行预测。本案例研究中的系统是标称质量在404至853原子质量单位之间的有机物质,涵盖了广泛的官能团和有机分子结构基序。结果表明,QCEIMS方法即使对于较大分子,在无偏差计算电子电离质谱方面也具有广泛的适用性。强调了在此类情况下其与标准(静态)或数据库驱动方法相比的优势。还讨论了关于所需计算时间或所用量子化学方法的近似性质的弱点。我们提出QCEIMS作为预测与药物化学和制药化学相关的相当大有机分子的电子电离质谱的一种可行且稳健的方法。